Portfolio Expansion (Generics)
Various Oncology Indications
CommercialActive
Key Facts
About Bendalis
Bendalis GmbH is a private, commercial-stage pharmaceutical company specializing in generic oncology and supportive care products. Founded in 2006 and headquartered in Oberhaching (near Munich), it operates with a therapeutics business model, generating revenue through the distribution of a portfolio of established injectable and oral generic drugs. The company leverages a close partnership with its sister company, Lyomark Pharma GmbH, a contract manufacturer, and focuses on the German and select international markets through a network of distribution partnerships.
View full company profileTherapeutic Areas
Other Various Oncology Indications Drugs
| Drug | Company | Phase |
|---|---|---|
| Bevacizumab Biosimilar | Hansoh Pharma | Approved |
| Companion Diagnostic Development | Genomic Testing Cooperative | Development |